INM — InMed Pharmaceuticals Share News
0.000.00%
Last trade - 00:00U.S. STOCKS ON THE MOVE-Natera, Grab, InMed
InMed starts studying effects of cannabinoids on nerve diseases; shares rise
Brief: Inmed Pharmaceuticals Advances Neurodegenerative Disease Program
Brief: Inmed Pharmaceuticals Reports First Quarter 2023 Loss Per Share $4.06
Brief: Inmed Pharmaceuticals Inc Files For Offer And Resale Of 2.1 Mln Common Shares By The Selling Shareholders
InMed Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary
Brief: Inmed Pharmaceuticals Reports Full Year Fiscal 2022 Financial Results And Provides Business Update
InMed Pharmaceuticals Inc expected to post a loss of $5.50 a share - Earnings Preview
Brief: Inmed Pharmaceuticals Announces Closing Of $6 Mln Private Placement Priced At A Premium To Market
U.S. STOCKS ON THE MOVE-Dow Inc, Corteva, Marker Therapeutics
U.S. STOCKS ON THE MOVE-Perrigo, FG Financial, Alector
U.S. STOCKS ON THE MOVE-Metal miners, Rambus, Nuwellis
U.S. STOCKS ON THE MOVE-Titan Medical, Gold miners, Relay Therapeutics
InMed Pharmaceuticals down on $6 million discounted private placement
U.S. STOCKS ON THE MOVE-OFS Credit, Nike, Elevance Health
U.S. STOCKS ON THE MOVE-CytoSorbents, Tapestry, Wayfair
U.S. STOCKS ON THE MOVE-Mogu, Energy firms, Kroger
InMed Pharmaceuticals surges, catches retail investor attention
U.S. STOCKS ON THE MOVE-Ecoark, Akero, Apple